The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Clinical Utility of the PFA-100
Open accessAbstract
The PFA-100 (platelet function analyzer) is a relatively new tool for the investigation of primary hemostasis. This article reviews the history of the PFA-100 and details its clinical utility in several settings. The PFA-100 was first introduced to us in 1995 in an issue of Seminars in Thrombosis And Hemostasis, which included data from a field trial headed by Dr. Eberhard Mammen. Since that time, the PFA-100 has featured in nearly 500 publications and some 35 reviews. The PFA-100 has potential utility in monitoring antiplatelet therapy (including aspirin) and as a screening tool for investigating possible von Willebrand disease (VWD) and various platelet disorders. The PFA-100 also has potential value for monitoring DDAVP (desmopressin) therapy in both VWD and functional platelet disorders. Most recent attention has focused on sensitivity to antiplatelet medication, where a new language has also emerged, with researchers talking about "aspirin resistance," "aspirin responsiveness," and "aspirin nonresponsiveness." Ultimately, the greatest strengths of the PFA-100 are its simplicity in use and excellent sensitivity to various hemostatic disturbances. However, because it is a "global" test system for primary hemostasis, this also creates a significant limitation because the PFA-100 is not specific for, nor predictive of, any particular disorder. However, used appropriately, the PFA-100 can be considered a worthwhile addition to hemostasis laboratories involved in the identification or therapeutic monitoring of primary hemostatic disorders. The potential future applications for this simple instrument are also briefly assessed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
Krasopoulos, G., Brister, S. J., Beattie, W. S., & Buchanan, M. R. (2008) · BMJ · doi:10.1136/bmj.39430.529549.be · Cited by 708
HAYWARD, C. P. M., HARRISON, P., CATTANEO, M., ORTEL, T. L., & RAO, A. K. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01771.x · Cited by 404
Avidan, M. S., Alcock, E. L., Da Fonseca, J., Ponte, J., Desai, J. B., Despotis, G. J., & Hunt, B. J. (2004) · British Journal of Anaesthesia · doi:10.1093/bja/aeh037 · Cited by 303
Diesel Exhaust Particles in Lung Acutely Enhance Experimental Peripheral Thrombosis
Nemmar, A., Hoet, P. H. M., Dinsdale, D., Vermylen, J., Hoylaerts, M. F., & Nemery, B. (2003) · Circulation · doi:10.1161/01.cir.0000053568.13058.67 · Cited by 299
Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction
Jilma, B. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.117406 · Cited by 262
Platelet function predicts myocardial damage in patients with acute myocardial infarction
Frossard, M., Fuchs, I., Leitner, J. M., Hsieh, K., Vlcek, M., Losert, H., Domanovits, H., Schreiber, W., Laggner, A. N., & Jilma, B. (2004) · Circulation · doi:10.1161/01.cir.0000141575.92958.9c · Cited by 254
Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis
Nemmar, A., Hoylaerts, M. F., Hoet, P. H. M., Vermylen, J., & Nemery, B. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00024-8 · Cited by 237
Cammerer, U., Dietrich, W., Rampf, T., Braun, S. L., & Richter, J. A. (2003) · Anesthesia & Analgesia · doi:10.1097/00000539-200301000-00011 · Cited by 224
Monitoring of Aspirin (ASA) Pharmacodynamics with the Platelet Function Analyzer PFA-100®
Homoncik, M., Hergovich, N., Stohlawetz, P., Panzer, S., Speiser, W., & Jilma, B. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613805 · Cited by 198
Rudnicka, A. R., Rumley, A., Lowe, G. D. O., & Strachan, D. P. (2007) · Circulation · doi:10.1161/circulationaha.106.635169 · Cited by 186
Cited by
Measurement of whole blood thrombus formation using parallel-plate flow chambers–a practical guide
Van Kruchten, R., Cosemans, J. M. E. M., & Heemskerk, J. W. M. (2012) · Platelets · doi:10.3109/09537104.2011.630848 · Cited by 153
Metadata
- Authors
- Favaloro, E.
- Venue
- Seminars in Thrombosis and Hemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2008-11
- Volume
- 34
- Issue
- 08
- Pages
- 709-733
- ISSN
- 0094-6176 (ISSN-L)
- 1098-9064
- OpenAlex
- W2059871051
- Cited by
- 279
- References
- 42
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Utility of the PFA-100. https://app.cochat.ai/papers/10.1055/s-0029-1145254
- The paper
- Favaloro, E. (2008). Clinical Utility of the PFA-100. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/s-0029-1145254
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.